Asia Pacific Antimicrobial Susceptibility Testing Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2023 –2029 |
 Marktgröße (Basisjahr) | USD 885.03 Million |
 Marktgröße (Prognosejahr) | USD 1,519.29 Million |
 CAGR |
% |
| Wichtige Marktteilnehmer |
|
>Asia-Pacific Antimicrobial Susceptibility Testing Market, By Product Type (Instruments, Consumables & Accessories, and Services & Software), Methods (Mass Spectrometry Method, Dilution, Disk Diffusion, E-Test, Genotypic Methods & Others), Type (Antibacterial Testing, Antifungal Testing & Rapid-AST), Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology & Others), End User (Hospitals, Pharmaceuticals and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, Research Centres and Academic Institutes & Others), Distribution Channel (Direct Sales, Retail Sales & Third Party Distributor), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific) Industry Trends and Forecast to 2029.
Market Analysis and Insights: Asia-Pacific Antimicrobial Susceptibility Testing Market
Antimicrobial susceptibility testing market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2022 to 2029 and is expected to reach USD 1,519.29 million by 2029 from USD 885.03 million in 2021. The high prevalence of infectious diseases and increasing awareness towards early diagnosis is the major driver which is propelling the market in the forecast period.
Antimicrobial susceptibility testing (AST) is a laboratory procedure which is used to determine which antimicrobial impedes the growth of bacteria, fungi, and other microorganism causing a specific infection. Susceptibility testing is performed on microorganisms such as bacteria, fungi causing the infection after they have been recovered in a culture of the specimen.
Antibacterial drugs are playing the important role in the prevention of infectious diseases, however, the cases of drug misuse and overuse, led to the development of drug resistance. Delay in diagnosing the harmful microbes makes it difficult to control the spread of infectious diseases. This is putting pressure on the key players to manufacture the test kits which gives accurate and effective results to better treat the patients.
Testing is used to determine the potential effectiveness of antibiotics on microorganisms and determine if the microorganisms have developed resistance to certain antibiotics. The results of this test can help healthcare professionals to get access to better clinical diagnosis and select the drug that is most likely to be effective in treating that particular infection.
Der Marktbericht für antimikrobielle Empfindlichkeitstests im asiatisch-pazifischen Raum enthält Einzelheiten zu Marktanteilen, neuen Entwicklungen und Produktpipeline-Analysen, Auswirkungen inländischer und lokaler Marktteilnehmer, analysiert Chancen in Bezug auf neue Umsatzquellen, Änderungen der Marktvorschriften, Produktzulassungen, strategische Entscheidungen, Produkteinführungen , geografische Expansionen und technologische Innovationen auf dem Markt. Um die Analyse und das Marktszenario zu verstehen, kontaktieren Sie uns für ein Analyst Briefing. Unser Team hilft Ihnen dabei, eine Umsatzauswirkungslösung zu entwickeln, mit der Sie Ihr gewünschtes Ziel erreichen.
Marktumfang und Marktgröße für antimikrobielle Empfindlichkeitstests im asiatisch-pazifischen Raum
Der Markt für antimikrobielle Empfindlichkeitstests im asiatisch-pazifischen Raum ist in sechs wichtige Segmente unterteilt, die auf Produkttyp, Methoden, Typ, Anwendung, Endbenutzer und Vertriebskanal basieren.
- Auf der Grundlage des Produkttyps ist der Markt für antimikrobielle Empfindlichkeitstests in Instrumente, Verbrauchsmaterialien und Zubehör sowie Dienstleistungen und Software unterteilt. Im Jahr 2022 wird das Instrumentensegment voraussichtlich den Markt dominieren, da die wichtigsten Akteure auf dem Markt auf hohe Technologie setzen.
- Auf der Grundlage der Methoden ist der Markt für antimikrobielle Empfindlichkeitstests in Massenspektrometriemethoden, Verdünnung, Diskdiffusion, E-Test, genotypische Methoden und andere unterteilt. Im Jahr 2022 wird die Diskdiffusionsmethode aufgrund ihrer genauen, zuverlässigen und effizienten Ergebnisse voraussichtlich den Markt dominieren.
- Der Markt für antimikrobielle Empfindlichkeitstests ist nach Typ in antibakterielle Tests, antimykotische Tests und andere unterteilt. Im Jahr 2022 wird das Segment der antibakteriellen Tests voraussichtlich den Markt dominieren, da auf dem Markt eine große Anzahl von Tests verfügbar ist. Die Hersteller entwickeln eine große Anzahl von Instrumenten für Bakterientests.
- Auf der Grundlage der Anwendung ist der Markt für antimikrobielle Empfindlichkeitstests in klinische Diagnostik, Arzneimittelforschung und -entwicklung, Epidemiologie und andere unterteilt. Im Jahr 2022 wird das Segment der klinischen Diagnostik voraussichtlich den Markt dominieren, da diese Tests am häufigsten durchgeführt werden, um Mikroben zu erkennen und dem Mikrobiologen Zugang zu einer besseren klinischen Diagnose zu ermöglichen.
- Auf der Grundlage des Endverbrauchers ist der Markt für antimikrobielle Empfindlichkeitstests in Krankenhäuser, Pharma- und Biotechnologieunternehmen, Diagnoselabore, Auftragsforschungsinstitute, Forschungszentren und akademische Institute und andere unterteilt. Im Jahr 2022 wird das Krankenhaussegment voraussichtlich den Markt dominieren, da diese antimikrobiellen Tests in großem Umfang in Krankenhäusern durchgeführt werden. Im Krankenhaus stehen modernste Technologien zur Diagnose der Krankheit zur Verfügung, die dem medizinischen Personal helfen, die Patienten wirksam zu behandeln.
- Auf der Grundlage des Vertriebskanals ist der Markt für antimikrobielle Empfindlichkeitstests in Direktvertrieb, Einzelhandelsvertrieb und Drittanbieter unterteilt. Im Jahr 2022 wird das Direktvertriebssegment voraussichtlich den Markt dominieren, da die Verbraucher den Direktvertrieb bevorzugen, um von Rabatten, Großeinkäufen und einfacher Verfügbarkeit der Produkte zu profitieren.
Antimikrobielle Empfindlichkeitstests Markt – Länderebene Analyse
Der Markt für antimikrobielle Empfindlichkeitstests wird analysiert und Informationen zur Marktgröße werden nach Land, Produkttyp, Methoden, Typ, Anwendung, Endbenutzer und Vertriebskanal bereitgestellt.
Die im Marktbericht für antimikrobielle Empfindlichkeitstests im asiatisch-pazifischen Raum abgedeckten Länder sind China, Japan, Indien, Südkorea, Australien, Singapur, Thailand, Malaysia, Indonesien, die Philippinen und der Rest des asiatisch-pazifischen Raums.
In der Region Asien-Pazifik werden China und Indien im Prognosezeitraum von 2022 bis 2029 voraussichtlich die vielversprechendsten Wachstumsraten aufweisen, da große Unternehmen wie Thermo Fisher Scientific Inc. und Bio-Rad Laboratories Inc. in den Markt drängen und in die Entwicklung von Testmethoden investieren, die hochgenaue Ergebnisse mit minimaler Bearbeitungszeit ermöglichen.
Der Länderabschnitt des Berichts enthält auch Angaben zu einzelnen marktbeeinflussenden Faktoren und Änderungen der Regulierung auf dem Inlandsmarkt, die sich auf die aktuellen und zukünftigen Markttrends auswirken. Datenpunkte wie Neuverkäufe, Ersatzverkäufe , demografische Daten des Landes, Regulierungsgesetze und Import-/Exportzölle sind einige der wichtigsten Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Bei der Prognoseanalyse der Länderdaten werden auch die Präsenz und Verfügbarkeit von Marken aus dem asiatisch-pazifischen Raum und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken sowie die Auswirkungen der Vertriebskanäle berücksichtigt.
Steigende Finanzierung von Forschungs- und Testlaboren schafft neue Chancen für Akteure auf dem Markt für antimikrobielle Empfindlichkeitstests
Der Markt für antimikrobielle Empfindlichkeitstests bietet Ihnen außerdem eine detaillierte Marktanalyse für jedes Landwachstum in einer bestimmten Branche mit Verkaufszahlen von Methoden zur antimikrobiellen Empfindlichkeitsprüfung, Auswirkungen von Fortschritten bei der antimikrobiellen Empfindlichkeitsprüfung und Änderungen in regulatorischen Szenarien mit ihrer Unterstützung für den Markt für antimikrobielle Empfindlichkeitstests. Die Daten sind für den historischen Zeitraum 2012 bis 2020 verfügbar.
Wettbewerbsumfeld und Antibiotika-Empfindlichkeitstests Marktanteilsanalyse
Die Wettbewerbslandschaft auf dem Markt für antimikrobielle Empfindlichkeitstests liefert Details nach Wettbewerbern. Die enthaltenen Details sind Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, Produktionsstandorte und -anlagen, Stärken und Schwächen des Unternehmens, Produkteinführung, Produkttestpipelines, Produktzulassungen, Patente, Produktbreite und -umfang, Anwendungsdominanz, Technologie-Lebenslinienkurve. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus des Unternehmens in Bezug auf den Markt für antimikrobielle Empfindlichkeitstests.
Die wichtigsten Unternehmen, die auf dem Markt für Antibiotika-Empfindlichkeitstests tätig sind, sind unter anderem BD, Synbiosis, Zhuhai DL Biotech Co., Ltd, Mast Group Ltd., HiMedia Laboratories, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Creative Diagnostics, Genefluidics, Inc., Rosco Diagnostica A/S, ERBA Group, Liofilchem Srl, Alifax Srl, MERLIN Gesellschaft für mikrobiologische Diagnostika mbH, bioMérieux SA, Merck KGaA, Danaher, Accelerate Diagnostics, Inc., NuMedii, Inc. und BacterioScan, Inc. sowie weitere inländische und asiatisch-pazifische Akteure. DBMR-Analysten kennen die Stärken der Konkurrenz und erstellen für jeden Wettbewerber eine separate Wettbewerbsanalyse.
Darüber hinaus werden von den Unternehmen weltweit zahlreiche Produkteinführungen und Vereinbarungen initiiert, die ebenfalls den Markt für antimikrobielle Empfindlichkeitstests ankurbeln.
Zum Beispiel,
- Im April 2020 hat Thermo Fisher Scientific Inc. sein Portfolio für automatisierte und manuelle Antibiotika-Empfindlichkeitstests um Imipenem/Relebactam ARIS HiQ erweitert, das zur Behandlung von Harnwegsinfektionen eingesetzt werden kann. Es erweitert außerdem die Möglichkeiten für Antibiotika-Tests im klinischen Umfeld. Dies wird das Wachstum des Marktes in den kommenden Jahren vorantreiben.
Zusammenarbeit, Joint Ventures und andere Strategien der Marktteilnehmer stärken den Unternehmensmarkt im Markt für tragbare elektronische Geräte und bieten Unternehmen auch den Vorteil, ihr Angebot im Bereich antimikrobieller Empfindlichkeitstests zu verbessern.
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISE IN EPIDEMIC AND PANDEMIC OUTBREAK
5.1.2 INCREASING PREVALENCE OF MULTI-DRUG RESISTANCE ORGANISM
5.1.3 AVAILABILITY OF ADVANCED ANTIMICROBIAL SUSCEPTIBILITY TESTING METHODS
5.1.4 HIGH PREVALENCE OF INFECTIOUS DISEASES
5.1.5 DEVELOPMENT OF NEW GENOMIC IDENTIFICATION METHODS
5.2 RESTRAINTS
5.2.1 STRINGENT GOVERNMENT REGULATIONS
5.2.2 HIGH COSTS OF AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS
5.2.3 SHORTAGE OF SKILLED PERSONNEL
5.3 OPPORTUNITIES
5.3.1 INCREASING PRODUCT LAUNCHES
5.3.2 INCREASE IN FUNDING
5.3.3 STRATEGIC DECISIONS TAKEN BY KEY MARKET PLAYERS
5.4 CHALLENGES
5.4.1 EMERGENCE OF LOCAL PLAYERS
5.4.2 DELAYS BETWEEN CLINICAL BREAKPOINT AND ITS CLEARANCE
5.4.3 LACK OF CLINICAL DATA FROM FDA
6 IMPACT OF COVID-19 ON ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON DEMAND
6.3 IMPACT ON SUPPLY
6.4 KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19
6.5 CONCLUSION:
7 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 INSTRUMENTS
7.2.1 MANUAL
7.2.1.1 MINIATURIZED IDENTIFICATION SYSTEMS
7.2.1.2 SUSCEPTIBILITY TESTING DISCS
7.2.1.2.1 DODECA DISCS
7.2.1.2.1.1 GENERAL PURPOSE
7.2.1.2.1.2 GRAM NEGATIVE ORGANISM
7.2.1.2.1.3 GRAM POSITIVE ORGANISM
7.2.1.2.1.4 PSEUDOMONAS
7.2.1.2.1.5 UTI ORGANISMS
7.2.1.2.2 HEXA DISCS
7.2.1.2.2.1 GRAM NEGATIVE ORGANISMS
7.2.1.2.2.2 GRAM POSITIVE ORGANISMS
7.2.1.2.2.3 GENERAL PURPOSE
7.2.1.2.2.4 ANAEROBIC BACTERIA
7.2.1.2.2.5 ANTIFUNGAL
7.2.1.2.2.6 OTHERS
7.2.1.2.3 ICOSA DISCS
7.2.1.2.3.1 GENERAL PURPOSE
7.2.1.2.3.2 PSEUDOMONAS
7.2.1.2.3.3 UTI ORGANISMS
7.2.1.2.4 OCTO DISCS
7.2.1.2.4.1 GRAM NEGATIVE ORGANISMS
7.2.1.2.4.2 GRAM POSITIVE ORGANISMS
7.2.1.2.4.3 UTI ORGANISMS
7.2.1.2.4.4 PSEUDOMONAS
7.2.1.2.4.5 GENERAL PURPOSE
7.2.1.2.4.6 OTHERS
7.2.1.2.5 MIC STRIPS
7.2.1.2.5.1 COMBINATION ANTIBACTERIAL
7.2.1.2.5.2 DUAL ANTIBACTERIAL
7.2.1.2.5.3 MULTIPLE ANTIBACTERIAL
7.2.1.2.5.4 SINGLE ANTIBACTERIAL
7.2.1.2.5.5 ANTIFUNGAL
7.2.1.2.5.6 OTHERS
7.3 AUTOMATED IDENTIFICATION AND SUSCEPTIBILITY TESTING SYSTEM
7.4 CONSUMABLES & ACCESSORIES
7.4.1 REAGENTS & BROTHS
7.4.2 MEDIA
7.4.3 SUSCEPTIBILITY PANELS
7.4.4 OTHERS
7.5 SERVICES & SOFTWARE
8 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS
8.1 OVERVIEW
8.2 DISK DIFFUSION
8.3 DILUTION
8.4 MASS SPECTROMETRY METHOD
8.5 E-TEST
8.6 GENEOTYPIC METHODS
8.7 RAPID-AST
9 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE
9.1 OVERVIEW
9.2 ANTI BACTERIAL TESTING
9.3 ANTI FUNGAL TESTING
9.4 OTHERS
10 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 CLINICAL DIAGNOSTICS
10.3 DRUG DISCOVERY AND DEVELOPMENT
10.4 EPIDEMIOLOGY
10.5 OTHERS
11 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 DIAGNOSTIC LABORATORIES
11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.5 CONTRACT RESEARCH ORGANIZATIONS
11.6 RESEARCH CENTRES AND ACADEMIC INSTITUTES
11.7 OTHERS
12 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT SALES
12.3 RETAIL SALES
12.4 THIRD PARTY DISTRIBUTOR
13 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION
13.1 ASIA-PACIFIC
13.1.1 CHINA
13.1.2 JAPAN
13.1.3 INDIA
13.1.4 SOUTH KOREA
13.1.5 AUSTRALIA
13.1.6 SINGAPORE
13.1.7 THAILAND
13.1.8 MALAYSIA
13.1.9 INDONESIA
13.1.10 PHILIPPINES
13.1.11 REST OF ASIA-PACIFIC
14 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 THERMO FISHER SCIENTIFIC INC.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 BIOMÉRIEUX SA
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 MERCK KGAA
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 DANAHER
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 ACCELERATE DIAGNOSTICS, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENTS
16.6 ALIFAX S.R.L.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 BACTERIOSCAN, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 BD
16.8.1 COMPANY SNAPSHOT
16.8.2 REVENUE ANALYSIS
16.8.3 PRODUCT PORTFOLIO
16.8.4 RECENT DEVELOPMENTS
16.9 BIO-RAD LABORATORIES, INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 COMPANY SHARE ANALYSIS
16.9.4 PRODUCT PORTFOLIO
16.9.5 RECENT DEVELOPMENTS
16.1 CREATIVE DIAGNOSTICS
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 ERBA GROUP
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 GENEFLUIDICS, INC.
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 HIMEDIA LABORATORIES
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENTS
16.14 LIOFILCHEM S.R.L.
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENTS
16.15 MAST GROUP LTD.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENTS
16.16 MERLIN GESELLSCHAFT FUR MICROBIOLOGISCHE DIAGNOSTIKA MBH
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENTS
16.17 NUMEDII, INC.
16.17.1 COMPANY SNAPSHOT
16.17.2 TECHNOLOGY PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 ROSCO DIAGNOSTICA A/S
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 SYNBIOSIS
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 ZHUHAI DL BIOTECH CO., LTD
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
Tabellenverzeichnis
TABLE 1 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 2 ASIA PACIFIC INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 ASIA PACIFIC INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 4 ASIA PACIFIC MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 5 ASIA PACIFIC SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 ASIA PACIFIC DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 7 ASIA PACIFIC HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 8 ASIA PACIFIC ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 9 ASIA PACIFIC OCT0 DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 10 ASIA PACIFIC MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 11 ASIA PACIFIC CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 ASIA PACIFIC CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 13 ASIA PACIFIC SERVICES & SOFTWARE IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 15 ASIA PACIFIC DISK DIFFUSION IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 ASIA PACIFIC DILUTION IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 ASIA PACIFIC MASS SPECTROMETRY METHOD IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 ASIA PACIFIC E-TEST IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 ASIA PACIFIC GENEOTYPIC METHODS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 ASIA PACIFIC RAPID-AST IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC ANTI BACTERIAL TESTING IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 ASIA PACIFIC ANTI FUNGAL TESTING IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 ASIA PACIFIC OTHERS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 26 ASIA PACIFIC CLINICAL DIAGNOSTICS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 ASIA PACIFIC DRUG DISCOVERY AND DEVELOPMENT IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 ASIA PACIFIC EPIDEMIOLOGY IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 ASIA PACIFIC OTHERS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 31 ASIA PACIFIC HOSPITALS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 32 ASIA PACIFIC DIAGNOSTIC LABORATORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 ASIA PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 ASIA PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 ASIA PACIFIC RESEARCH CENTRES AND ACADEMIC INSTITUTES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 ASIA PACIFIC OTHERS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 38 ASIA PACIFIC DIRECT SALES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 39 ASIA PACIFIC RETAILS SALES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 40 ASIA PACIFIC THIRD PARTY DISTRIBUTOR IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 42 ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 43 ASIA-PACIFIC INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 44 ASIA-PACIFIC MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 45 ASIA-PACIFIC SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 46 ASIA-PACIFIC DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 47 ASIA-PACIFIC HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 48 ASIA-PACIFIC ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 49 ASIA-PACIFIC OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 50 ASIA-PACIFIC MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 51 ASIA-PACIFIC CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 52 ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 53 ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 54 ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 55 ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 56 ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 57 CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 58 CHINA INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 59 CHINA MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 60 CHINA SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 61 CHINA DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 62 CHINA HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 63 CHINA ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 64 CHINA OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 65 CHINA MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 66 CHINA CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 67 CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 68 CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 69 CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 70 CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 71 CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 72 JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 73 JAPAN INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 74 JAPAN MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 75 JAPAN SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 76 JAPAN DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 77 JAPAN HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 78 JAPAN ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 79 JAPAN OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 80 JAPAN MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 81 JAPAN CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 82 JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 83 JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 84 JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 85 JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 86 JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 87 INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 88 INDIA INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 89 INDIA MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 90 INDIA SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 91 INDIA DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 92 INDIA HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 93 INDIA ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 94 INDIA OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 95 INDIA MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 96 INDIA CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 97 INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 98 INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 99 INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 100 INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 101 INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 102 SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 103 SOUTH KOREA INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 104 SOUTH KOREA MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 105 SOUTH KOREA SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 106 SOUTH KOREA DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 107 SOUTH KOREA HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 108 SOUTH KOREA ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 109 SOUTH KOREA OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 110 SOUTH KOREA MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 111 SOUTH KOREA CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 112 SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 113 SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 114 SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 115 SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 116 SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 117 AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 118 AUSTRALIA INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 119 AUSTRALIA MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 120 AUSTRALIA SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 121 AUSTRALIA DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 122 AUSTRALIA HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 123 AUSTRALIA ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 124 AUSTRALIA OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 125 AUSTRALIA MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 126 AUSTRALIA CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 127 AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 128 AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 129 AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 130 AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 131 AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 132 SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 133 SINGAPORE INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 134 SINGAPORE MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 135 SINGAPORE SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 136 SINGAPORE DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 137 SINGAPORE HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 138 SINGAPORE ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 139 SINGAPORE OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 140 SINGAPORE MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 141 SINGAPORE CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 142 SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 143 SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 144 SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 145 SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 146 SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 147 THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 148 THAILAND INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 149 THAILAND MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 150 THAILAND SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 151 THAILAND DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 152 THAILAND HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 153 THAILAND ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 154 THAILAND OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 155 THAILAND MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 156 THAILAND CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 157 THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 158 THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 159 THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 160 THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 161 THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 162 MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 163 MALAYSIA INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 164 MALAYSIA MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 165 MALAYSIA SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 166 MALAYSIA DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 167 MALAYSIA HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 168 MALAYSIA ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 169 MALAYSIA OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 170 MALAYSIA MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 171 MALAYSIA CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 172 MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 173 MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 174 MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 175 MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 176 MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 177 INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 178 INDONESIA INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 179 INDONESIA MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 180 INDONESIA SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 181 INDONESIA DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 182 INDONESIA HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 183 INDONESIA ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 184 INDONESIA OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 185 INDONESIA MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 186 INDONESIA CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 187 INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 188 INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 189 INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 190 INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 191 INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 192 PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 193 PHILIPPINES INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 194 PHILIPPINES MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 195 PHILIPPINES SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 196 PHILIPPINES DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 197 PHILIPPINES HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 198 PHILIPPINES ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 199 PHILIPPINES OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 200 PHILIPPINES MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 201 PHILIPPINES CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 202 PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 203 PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 204 PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 205 PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 206 PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 207 REST OF ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
Abbildungsverzeichnis
FIGURE 1 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIILITY TESTING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: SEGMENTATION
FIGURE 11 RISE IN EPIDEMIC AND PANDEMIC OUTBREAK AND INCREASING PREVALENCE OF MULTI-DRUG RESISTANT ORGANISM IS EXPECTED TO DRIVE THE ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2022 & 2029
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
FIGURE 15 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY PRODUCT TYPE, 2021
FIGURE 16 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY PRODUCT TYPE, 2020-2029 (USD MILLION)
FIGURE 17 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 18 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 19 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY METHODS, 2021
FIGURE 20 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY METHODS, 2020-2029 (USD MILLION)
FIGURE 21 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY METHODS, CAGR (2022-2029)
FIGURE 22 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY METHODS, LIFELINE CURVE
FIGURE 23 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY TYPE, 2021
FIGURE 24 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY TYPE, 2020-2029 (USD MILLION)
FIGURE 25 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 26 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY TYPE, LIFELINE CURVE
FIGURE 27 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY APPLICATION, 2021
FIGURE 28 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY APPLICATION, 2020-2029 (USD MILLION)
FIGURE 29 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 30 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 31 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY END USER, 2021
FIGURE 32 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY END USER, 2020-2029 (USD MILLION)
FIGURE 33 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY END USER, CAGR (2022-2029)
FIGURE 34 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY END USER, LIFELINE CURVE
FIGURE 35 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 36 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
FIGURE 37 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 38 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 39 ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: SNAPSHOT (2021)
FIGURE 40 ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY COUNTRY (2021)
FIGURE 41 ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY COUNTRY (2022 & 2029)
FIGURE 42 ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY COUNTRY (2021 & 2029)
FIGURE 43 ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 44 ASIA PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: COMPANY SHARE 2021 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
